BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29150359)

  • 1. Azathioprine-induce acute submandibular sialadenitis in a patient with Crohn's disease.
    Guerra Romero A; Pérez Calle JL; López Serrano P
    Gastroenterol Hepatol; 2018 Nov; 41(9):570-571. PubMed ID: 29150359
    [No Abstract]   [Full Text] [Related]  

  • 2. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E; Macdonald JK; Sutherland LR
    Cochrane Database Syst Rev; 2009 Oct; (4):CD000545. PubMed ID: 19821270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: balance.
    Jacobstein DA; Baldassano RN
    Inflamm Bowel Dis; 2005 Feb; 11(2):203-5. PubMed ID: 15677916
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of 6-mercapturine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: con.
    Griffiths AM
    Inflamm Bowel Dis; 2005 Feb; 11(2):200-2. PubMed ID: 15677915
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term immunosuppressive treatment in Crohn's disease.
    Nyman M; Hansson I; Eriksson S
    Scand J Gastroenterol; 1985 Dec; 20(10):1197-203. PubMed ID: 3912958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.
    Bouhnik Y; Lémann M; Mary JY; Scemama G; Taï R; Matuchansky C; Modigliani R; Rambaud JC
    Lancet; 1996 Jan; 347(8996):215-9. PubMed ID: 8551879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe pancytopenia from thiopurine methyltransferase deficiency: a preventable complication of 6-mercaptopurine therapy in children with Crohn disease.
    Rosen R; Integlia MJ; Bousvaros A
    J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):695-9. PubMed ID: 12454589
    [No Abstract]   [Full Text] [Related]  

  • 8. TPMT in the treatment of Crohn's disease with azathioprine.
    Lennard L
    Gut; 2002 Aug; 51(2):143-6. PubMed ID: 12117866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Crohn's disease: no advantage by azathioprine and 6-mercaptopurine].
    Schreiber S
    Dtsch Med Wochenschr; 2013 Sep; 138(38):1877. PubMed ID: 24022448
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunosuppression in patients with Crohn's disease and neoplasia: an ongoing clinical dilemma.
    Dasari BV; McBrearty A; Gardiner K
    Dis Colon Rectum; 2012 Sep; 55(9):1008-11. PubMed ID: 22874610
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypersensitivity to azathioprine in a patient with Crohn's disease: a case report.
    Sousa M; Proença L; Carvalho J
    Rev Esp Enferm Dig; 2017 Oct; 109(10):735. PubMed ID: 28929775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azathioprine and 6 Mercaptopurine in postoperative maintenance of Crohn's disease remission: is no evidence of effect an evidence of no effect?
    Mardini HE
    Gastroenterology; 2005 Jan; 128(1):246-8; author reply 248-9. PubMed ID: 15633153
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acute azathioprine-induced pancreatitis in a female patient with Crohn's disease].
    Velicia MR; González JM; Fernández P; Remacha B; Martín MA; Sánchez G; Goyeneche ML; Caro-Paton A
    Gastroenterol Hepatol; 1999 Apr; 22(4):186-7. PubMed ID: 10349790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hodgkin's lymphoma in a patient with Crohn's disease treated with azathioprine and antibodies anti tumor necrosis factor α].
    Sagüés M; Navarro JT; Ribera JM; Millá F
    Med Clin (Barc); 2012 Apr; 138(8):366-7. PubMed ID: 21752407
    [No Abstract]   [Full Text] [Related]  

  • 15. [Myelotoxicity due to interaction between azathioprine and allopurinol in a patient with Crohn's disease].
    Millán M; Castro-Fernández M; Ampuero J; Romero-Gómez M
    Gastroenterol Hepatol; 2013 Apr; 36(4):298-9. PubMed ID: 23274032
    [No Abstract]   [Full Text] [Related]  

  • 16. Kaposi's sarcoma developing in a HIV-negative Crohn's disease patient shortly after azathioprine and corticosteroid treatment.
    Kilincalp S; Akıncı H; Hamamci M; Coşkun Y; Yüksel I
    J Crohns Colitis; 2014 Jun; 8(6):558-9. PubMed ID: 24291020
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-cirrhotic portal hypertension due to 6-mercaptopurine use for Crohn's disease.
    Pola S; Boland BS; Lin GY; Kuo A; Sandborn WJ
    Dig Dis Sci; 2014 Jul; 59(7):1642-4. PubMed ID: 24535249
    [No Abstract]   [Full Text] [Related]  

  • 18. [Azathioprine-induced hepatotoxicity in a patient with Crohn's disease].
    Ruiz-Clavijo D; Arín A; Vila JJ; Albéniz E; Picazo R; Casi M
    An Sist Sanit Navar; 2013 Sep; 36(2):353-6. PubMed ID: 24008542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Veno-occlusive disease (VOD) in Crohn's disease (CD) treated with azathioprine.
    Holtmann M; Schreiner O; Köhler H; Denzer U; Neurath M; Galle PR; Höhler T
    Dig Dis Sci; 2003 Aug; 48(8):1503-5. PubMed ID: 12924643
    [No Abstract]   [Full Text] [Related]  

  • 20. Histoplasma epiglottitis in a patient with Crohn's disease maintained on infliximab, prednisone, and azathioprine.
    Abou Zahr A; Saad Aldin E; Yunyongying P
    Int J Infect Dis; 2013 Aug; 17(8):e650-2. PubMed ID: 23769453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.